St. Jude Medical
 |
|
| Type |
Public (NYSE: STJ) S&P 500 Component |
|---|---|
| Industry | Medical device manufacturer |
| Founded | 1976 |
| Headquarters | Little Canada, Minnesota |
| Key people |
Daniel J. Starks, Chairman and CEO John C. Heinmiller, Executive Vice President & Chief Financial Officer |
| Net income |
 USD 384.33 million (2008) |
| Website | www.sjm.com |
St. Jude Medical, Inc. (NYSE: STJ) is a $16 billion (market cap) global medical device company, with headquarters in Little Canada, Minnesota, United States, a suburb of St. Paul. The company sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide. Its principal competitors are Medtronic and Boston Scientific.
St. Jude Medical develops and manufactures the following types of products:
- Cardiac resynchronization therapy devices for heart failure
- Artificial pacemakers and implantable cardioverter defibrillators (ICDs) for treating cardiac rhythm disorders
- Diagnostic and therapeutic electrophysiology catheters
- Introducers, catheters, and vascular closure devices for cardiology and vascular access
- Mechanical and tissue heart valves plus valve repair products
- Spinal cord stimulators for intractable pain (under subsidiary "Advanced Neuromodulation System" based in Plano, Texas)
External links
References
|
|||||||||||
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
